Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
L.GarberA
Prescribing Information: Zepbound (tirzepatide) Injection, for subcutaneous use
Competitive Landscape for Market Players The GLP-1 receptor agonist market is characterized by a concentrated competitive landscape dominated by Novo Nordisk and Eli Lilly, with emerging challengers advancing next-generation molecules
The enzyme activity of GDH in hepatocytes is 4.5 times that of other tissues
Properly stored inventory arrives with maximum remaining shelf life
read more Close window Immuno-Grade GLP1 Receptor Antibodies The glucagon-like peptide-1 receptor (GLP1) is a class B G protein-coupled receptor that plays a crucial role in the regulation of glucose metabolism and energy balance
US$ 27.02
US$ 25.45
US$ 24.48
US$ 27.09
US$ 29.83
US$ 21.47
